 Hoth Therapeutics Inc NASDAQ: HOTH has announced proof-of-concept data generated using cognitive and behavioral assessments in an Alzheimers disease mouse model. HT-ALZ is therapeutic in development under the 505b2 regulatory pathway for dementia related to Alzheimer. 